• Protocols

• UW16044

  OPEN TO ACCRUAL

  Phase I/II Ribociclib and Bicalutamide in AR+ TNBC
  
  

• UW24004

  OPEN TO ACCRUAL

  P3 Study: Dato-DXd With or Without Durvalumab VS. Choice Chemo + Pembro in Pt w/PD-L1+ or Met TNBC